The Valley Desk

NCT07222332 · Interventional trial

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

Overall registry status Recruiting

Phase 3

Conditions Diabetes Mellitus, Type 1

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov